HSP90B1 and neoplasm: Placental gp96-pulsed BMDC immunization also dramatically enhanced the survival time of tumor-burdened mice (Fig 3C and 3E, P<0.01 for both B16-F10 and LLC model), and prolonged mice survival compared with placental gp96 immunization alone (P<0.05 for LLC model).